2-hydroxy-3-(3-methoxyphenyl)prop-2-enoic acid, 95%, 100mg

1-(3-Chlorophenyl)-3-thiophen-2-yl-1H-pyrazole-5-carboxylic acid, = 98% (HPLC), 1g

2-Methyl-5,10-dihydro-4H-benzo[b]thieno[2,3-e][1,4]diazepin-4-one, 95.0%, 250mg

tert-Butyl 4,7-diazaspiro[2.5]octane-7-carboxylate, 95.0%, 100g

Isobutyraldehyde 2,4-Dinitrophenylhydrazone>98.0%(T)1g

2-Cyclopropyl-8-methylquinoline-4-carboxylic acid, 95%, 100mg

1-Ethyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)thiourea, 97%, 5g

Rotilabo®-Präparatezylinder, H 300 mm, Borosilikatglas, Ø Deckel außen 314 mm, 1 Stück

6-bromo-5-methyl-1H,2H,3H-imidazo[4,5-b]pyridine-2-thione, 97%, 250mg

3-Aminopropyldimethylethoxysilane, 95%, 5g

1-isopropyl-5-methyl-1H-pyrazole-3-carbonyl chloride, 95.0%, 250mg

2-(1'-(tert-Butoxycarbonyl)-2,3-dihydrospiro[indene-1,4'-piperidin]-3-yl)acetic acid, 97%, 100mg

2-Ethyl-1-hexene>95.0%(GC)10mL